Amsterdam, Netherlands – In a significant move for neurological healthcare, Royal Philips has announced an expanded partnership with Cortechs.ai to advance quantitative neuroimaging technology. The collaboration, announced on November 19, 2025, represents a major step forward in precision diagnostics for brain-related conditions.
Transforming Neurological Diagnosis Through AI Integration
The extended partnership will integrate Cortechs.ai's advanced AI-enabled neuroimaging analytics directly into Philips' MR systems. This integration aims to provide clinicians with faster, more objective, and reproducible insights into brain health. The collaboration strengthens Philips' position in precision neuro diagnostics by combining their next-generation MR technologies with Cortechs.ai's AI-driven quantitative neuroimaging post-processing software.
This development comes at a critical time for healthcare systems. Current data shows that up to 25% of all MR procedures are brain scans, with radiology departments facing growing demand amid increasing staff shortages. Meanwhile, the global incidence of neurological conditions such as Alzheimer's disease, multiple sclerosis, and brain tumors continues to rise.
Addressing Critical Healthcare Challenges
Traditional MR interpretation of neurodegenerative diseases and neuro-oncology cases has heavily depended on visual assessment, introducing variability and requiring significant expertise and time in already overloaded healthcare systems. The Philips-Cortechs.ai partnership aims to address these challenges by delivering more standardized and data-driven imaging solutions.
Through this collaboration, quantitative analysis tools including brain volumetrics, lesion quantification, and tumor tracking will be integrated directly into the Philips MR imaging workflow. This integration provides clinicians with objective, numerical data alongside images, enabling faster, more consistent, and confident diagnoses.
Streamlining Clinical Workflows with Zero-Click Technology
The integration of Cortechs.ai's NeuroQuant® solutions for Alzheimer's, MS, and brain tumors within Philips' Smart Reading environment marks a significant advancement in precision neuroimaging. This cloud-based AI platform combines imaging, reading, and reporting directly on MR systems.
Clinicians will automatically receive AI-generated quantitative reports within their standard MR workflow on the MR system or PACS, without requiring additional steps from technologists. This zero-click process ensures quality-checked data and standardized outputs, helping radiologists interpret brain scans more objectively and with greater confidence.
"By extending our partnership with Cortechs.ai, we are accelerating the transition to fully quantitative, AI-powered neuroimaging," said Ioannis Panagiotelis, PhD, Business Leader, MRI at Philips. "This integration brings precision, reproducibility, and efficiency to neurological MR, helping clinicians make faster, more confident decisions for patients living with complex brain conditions."
The partnership represents Philips' broader strategy to drive productivity and improve care through deep AI integration. By automatically generating quantitative reports within existing workflows, the technology helps radiologists save time, improve consistency, and boost throughput. Objective numerical biomarkers enhance diagnostic accuracy, enabling more reproducible assessments and confident comparisons across different time points and healthcare facilities.
This automated, quality-controlled workflow minimizes manual post-processing, allowing technologists to focus more on delivering better, more personalized patient experiences. The collaboration between Philips and Cortechs.ai signals a new era in neurological diagnostics, where AI-powered precision meets clinical practicality.
